SCHEMBL29790129

SCHEMBL29790129

NC(=O)c1cc2ccccc2n2ncnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.42
MAP2K1 Q02750 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
LMNA P02545 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 4/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 2/20 0.37
PARP1 P09874 5/20 0.37
TLR8 Q9NR97 2/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
CDC7 O00311 1/20 0.36
HTT P42858 1/20 0.35
PLA2G10 O15496 1/20 0.35
SLC9A1 P19634 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29790049 0.82 KDM4E (0.45) IKBKBMAP2K1CLK4DYRK1BKDM4E
SCHEMBL22902757 0.79 LCK (0.42) IKBKBMAP2K1CLK4DYRK1BKDM4E
SCHEMBL4497379 0.77 MEN1 (0.54) IKBKBRAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL22902849 0.75 ADORA2A (0.45) CLK4DYRK1BRAB9AKDM4EALDH1A1
SCHEMBL29789954 0.73 IKBKB (0.42) IKBKBMAP2K1CLK4DYRK1BKDM4E
SCHEMBL22902872 0.72 MAP2K1 (0.38) MAP2K1CLK4DYRK1BLMNASMN1; SMN2
SCHEMBL29522301 0.72 IKBKB (0.43) IKBKBMAP2K1CLK4DYRK1BLMNA
SCHEMBL29790141 0.70 IKBKB (0.41) IKBKBRAB9AKDM4EALDH1A1GAA
SCHEMBL1004596 0.67 KDM4E (0.63) IKBKBLMNARAB9ASMN1; SMN2KDM4E
SCHEMBL9849401 0.67 DAO (0.50) IKBKBKDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3999508-A1 TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS IRAK4 INHIBITORS Bristol-Myers Squibb Company (US) 2022-05-25 EP disclosed